The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis – A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up
Author:
Funder
Taiwan Ministry of Science and Technology
National Taiwan University Hospital
National Taiwan University College of Medicine
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference36 articles.
1. Trastuzumab--mechanism of action and use in clinical practice;Hudis;N Engl J Med,2007
2. Lapatinib plus capecitabine for HER2-positive advanced breast cancer;Geyer;N Engl J Med,2006
3. Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial;Gianni;Lancet Oncol,2011
4. Trastuzumab emtansine for HER2-positive advanced breast cancer;Verma;N Engl J Med,2012
5. Drug-induced interstitial lung disease: a systematic review;Skeoch;J Clin Med,2018
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxicity, and survival in HER2-positive breast cancer patients;Clinical and Translational Oncology;2024-05-21
2. Pharmacoepidemiology Study of Antibody-Drug Conjugate-Associated Interstitial Lung Disease;2024
3. Multidisciplinary clinical guidelines in proactive monitoring, early diagnosis, and effective management of trastuzumab deruxtecan (T-DXd)-induced interstitial lung disease (ILD) in breast cancer patients;ESMO Open;2023-12
4. First reported case of ANCA-associated vasculitis induced by oxaliplatin, capecitabine, and trastuzumab;Renal Failure;2023-11-17
5. Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target;Biomarker Research;2023-03-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3